Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients

por Guerriero, Fabio, Sgarlata, Carmelo, Marcassa, Claudio, Ricevuti, Giovanni, Rollone, Marco
Publicado 2014

Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis

por Lazzari, Marzia, Greco, Maria Teresa, Marcassa, Claudio, Finocchi, Simona, Caldarulo, Clarissa, Corli, Oscar
Publicado 2015

Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation

por Lazzari, Marzia, Marcassa, Claudio, Natoli, Silvia, Carpenedo, Roberta, Caldarulo, Clarissa, Silvi, Maria B, Dauri, Mario
Publicado 2016

Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study

por Petrò, Emiliano, Ruffini, Elena, Cappuccio, Melania, Guerini, Valeria, Belotti, Gloria, Fascendini, Sara, Licini, Cristina, Marcassa, Claudio
Publicado 2016

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis

por De Santis, Stefano, Borghesi, Cristina, Ricciardi, Serena, Giovannoni, Daniele, Fulvi, Alberto, Migliorino, Maria Rita, Marcassa, Claudio
Publicado 2016

Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

por Bandinelli, Francesca, Scazzariello, Francesco, Pimenta da Fonseca, Emanuela, Barreto Santiago, Mittermayer, Marcassa, Claudio, Nacci, Francesca, Matucci Cerinic, Marco
Publicado 2016